Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shiyun Xian, Jiabin Zhu, Yuchen Wang, Haihan Song & Hangxiang Wang. (2023) Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice. Drug Delivery 30:1.
Read now
Read now
Mahfoozur Rahman, Vikas Kumar, Sarwar Beg, Gajanand Sharma, Om Prakash Katare & Firoz Anwar. (2016) Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artificial Cells, Nanomedicine, and Biotechnology 44:7, pages 1597-1608.
Read now
Read now
John Youshia & Alf Lamprecht. (2016) Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases. Expert Opinion on Drug Delivery 13:2, pages 281-294.
Read now
Read now
Jian-Xin Zhang, Kun Wang, Zheng-Fa Mao, Xin Fan, De-Li Jiang, Min Chen, Lei Cui, Kang Sun & Sheng-Chun Dang. (2013) Application of liposomes in drug development — focus on gastroenterological targets. International Journal of Nanomedicine 8, pages 1325-1334.
Read now
Read now
Omri Wolk, Svetlana Epstein, Viktoriya Ioffe-Dahan, Shimon Ben-Shabat & Arik Dahan. (2013) New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities. Expert Opinion on Drug Delivery 10:9, pages 1275-1286.
Read now
Read now
Sandra Simões, Cláudia Marques, Maria Eugénia Cruz & Maria Bárbara Figueira Martins. (2009) Anti-inflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model. Journal of Microencapsulation 26:7, pages 649-658.
Read now
Read now
Articles from other publishers (54)
Bhuvanesh Yathavan, Alexa Ellis, Jolanta Jedrzkiewicz, Nithya Subrahmanyam, Nitish Khurana, Abigail Pulsipher, Jeremiah A. Alt & Hamidreza Ghandehari. (2023) Systemic administration of budesonide in pegylated liposomes for improved efficacy in chronic rhinosinusitis. Journal of Controlled Release 360, pages 274-284.
Crossref
Crossref
Mingyi Li, Jia Liu, Lin Shi, Cheng Zhou, Meizhen Zou, Daan Fu, Ye Yuan, Chundong Yao, Lifang Zhang, Sumei Qin, Miaodeng Liu, Qian Cheng, Zheng Wang & Lin Wang. (2023) Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease. Bioactive Materials 25, pages 95-106.
Crossref
Crossref
Xiaojie Wang, Jun Yang, Shuai Luo, Hucheng Zhang, Bo Liu & Zhiquan Pan. (2023) Study of Salidroside and Its Inflammation Targeting Emulsion Gel for Wound Repair. Molecules 28:13, pages 5151.
Crossref
Crossref
Yongliang Ouyang, Jiulong Zhao & Shige Wang. (2023) Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review. International Journal of Biological Macromolecules 227, pages 505-523.
Crossref
Crossref
Hongyao Zhong, Huanxiao Zhang, Yiwei Hu, Shoukai He, Huiting Qu, Jie He, Jianqing Chen, Jinghua Chen, Leyao Zhang & Chao Deng. (2023) Self-assembled micelle derived from pterostilbene ameliorate acute inflammatory bowel disease. International Journal of Pharmaceutics 630, pages 122420.
Crossref
Crossref
Sahar Mohajeri, Saeed Moayedi, Shabnam Mohajeri, Abbas Yadegar & Ismaeil Haririan. (2022) Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Fei Wang, Qianhui Li, Tingting Xu, Zhu Li, Yongxin Jiang, Yan Ma, Xiaohu Li, Wanni Wang & Haisheng Qian. (2022) An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. Fundamental Research.
Crossref
Crossref
Rui Wang, Kun Guo, Weijie zhang, Yineng He, Kai Yang, Qian Chen, Liang Yang, Zhengao Di, Jiangkai Qiu, Peng Lei, Yian Gu, Zhengshan Luo, Xiaoqi Xu, Zongqi Xu, Xiaohai Feng, Sha Li, Ziyi Yu & Hong Xu. (2022) Poly‐γ‐Glutamic Acid Microgel‐Encapsulated Probiotics with Gastric Acid Resistance and Smart Inflammatory Factor Targeted Delivery Performance to Ameliorate Colitis. Advanced Functional Materials 32:26.
Crossref
Crossref
Farah Yasmin, Hala Najeeb, Shehryar Shaikh, Muhammad Hasanain, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Syedadeel Hasan & Salim Surani. (2022) Novel drug delivery systems for inflammatory bowel disease. World Journal of Gastroenterology 28:18, pages 1922-1933.
Crossref
Crossref
Yingzheng Zhao, Pengpeng Xue, Gaolong Lin, Mengqi Tong, Jiaojiao Yang, Yingying Zhang, Kunjie Ran, Deli Zhuge, Qing Yao & Helin Xu. (2022) A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon. Acta Biomaterialia 143, pages 233-252.
Crossref
Crossref
Maria Eugénia Meirinhos Cruz, Maria Luísa Corvo, Maria Bárbara Martins, Sandra Simões & Maria Manuela Gaspar. (2022) Liposomes as Tools to Improve Therapeutic Enzyme Performance. Pharmaceutics 14:3, pages 531.
Crossref
Crossref
Lenka Poláková, Vladimír Raus, Lucie Cuchalová, Rafał Poręba, Martin Hrubý, Jan Kučka, David Větvička, Olga Trhlíková & Zdeňka Sedláková. (2022) SHARP hydrogel for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 613, pages 121392.
Crossref
Crossref
Niranjan G. Kotla, Rajbir Singh, Becca V. Baby, Swetha Rasala, Jawad Rasool, Sean O. Hynes, Darrell Martin, Laurence J. Egan, Praveen K. Vemula, Venkatakrishna R. Jala, Yury Rochev & Abhay Pandit. (2022) Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials 281, pages 121364.
Crossref
Crossref
Li Zhao, Fei Wang, Zhengwei Cai, Qi Zhou, Bo Chen, Chen Zhang, Hua Liu, Liwen Hong, Tianyu Zhang, Jie Zhong, Wenguo Cui & Zhengting Wang. (2021) Improving drug utilization platform with injectable mucoadhesive hydrogel for treating ulcerative colitis. Chemical Engineering Journal 424, pages 130464.
Crossref
Crossref
Yuan Cheng, Chaoqun Cheng, Jia Yao, Yijun Yu, Yufeng Liu, He Zhang, Leiying Miao & Hui Wei. (2021)
Mn
3
O
4
Nanozyme for Inflammatory Bowel Disease Therapy
. Advanced Therapeutics 4:9, pages 2100081.
Crossref
Crossref
Jiawei Li, Huiqiang Qiu, Hengtai Gong & Weijun Tong. (2021) Broad-Spectrum Reactive Oxygen Species Scavenging and Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease. Biomacromolecules 22:7, pages 3107-3118.
Crossref
Crossref
Jingguo Wang, Zhenchao Tao, Tian Tian, Jun Qiu, Haisheng Qian, Zhengbao Zha, Zhaohua Miao, Yan Ma & Hua Wang. (2021) Polyoxometalate nanoclusters: A potential preventative and therapeutic drug for inflammatory bowel disease. Chemical Engineering Journal 416, pages 129137.
Crossref
Crossref
Min Wang, Wensong Hao, Lei Zhang, Yanong Zhu, Kun Chen, Shuai Ma, Xinfeng Cheng & Jinsheng Zhao. (2021) Lipid-polymer nano core-shell type hybrid system for colon specific drug delivery. Journal of Drug Delivery Science and Technology 63, pages 102540.
Crossref
Crossref
Sheng Zhao, Yixuan Li, Quanyi Liu, Sirong Li, Yuan Cheng, Chaoqun Cheng, Ziying Sun, Yan Du, Christopher J. Butch & Hui Wei. (2020)
An Orally Administered CeO
2
@Montmorillonite Nanozyme Targets Inflammation for Inflammatory Bowel Disease Therapy
. Advanced Functional Materials 30:45, pages 2004692.
Crossref
Crossref
Yangyan Xiu, Kaizhen Wang, Jingfang Chen, Zhiqiang Zhuo & Yanghui Xiu. (2020)
Liposomal
N
-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis
. RSC Advances 10:56, pages 34197-34202.
Crossref
Crossref
Menghang Zu, Heliang Song, Jiabin Zhang, Qiubing Chen, Shiqin Deng, Brandon S.B. Canup, Yi Yuan & Bo Xiao. (2020) Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis. Colloids and Surfaces B: Biointerfaces 187, pages 110747.
Crossref
Crossref
Priscila Schilrreff, Yamila Roxana Simioni, Horacio Emanuel Jerez, Ayelen Tatiana Caimi, Marcelo Alexandre de Farias, Rodrigo Villares Portugal, Eder Lilia Romero & Maria Jose Morilla. (2019) Superoxide dismutase in nanoarchaeosomes for targeted delivery to inflammatory macrophages. Colloids and Surfaces B: Biointerfaces 179, pages 479-487.
Crossref
Crossref
Niranjan G. Kotla, Shubhasmin Rana, Gandhi Sivaraman, Omprakash Sunnapu, Praveen K. Vemula, Abhay Pandit & Yury Rochev. (2019) Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Advanced Drug Delivery Reviews 146, pages 248-266.
Crossref
Crossref
Mélanie Melo, Rute Nunes, Bruno Sarmento & José das Neves. (2018) Rectal administration of nanosystems: from drug delivery to diagnostics. Materials Today Chemistry 10, pages 128-141.
Crossref
Crossref
A. Bak, M. Ashford & D.J. Brayden. (2018) Local delivery of macromolecules to treat diseases associated with the colon. Advanced Drug Delivery Reviews 136-137, pages 2-27.
Crossref
Crossref
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang & Bing Wang. (2018) Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 23:7, pages 1622.
Crossref
Crossref
Sufeng Zhang, Robert Langer & Giovanni Traverso. (2017) Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease. Nano Today 16, pages 82-96.
Crossref
Crossref
Zeki Ozsoy, Seyma Ozsoy, Fikret Gevrek, Emre Demir, Ismail Benli, Emin Daldal & Erdinc Yenidogan. (2017) Effect of bevacizumab on acetic acid–induced ulcerative colitis in rats. Journal of Surgical Research 216, pages 191-200.
Crossref
Crossref
Shikha Srivastava, Deependra Singh, Satish Patel & Manju R. Singh. (2017) Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders. International Journal of Biological Macromolecules 101, pages 502-517.
Crossref
Crossref
Seyed Yaser Vafaei, Motahareh Esmaeili, Mohsen Amini, Fatemeh Atyabi, Seyed Naser Ostad & Rassoul Dinarvand. (2016) Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa. Carbohydrate Polymers 144, pages 371-381.
Crossref
Crossref
Thanh Xuan Nguyen, Lin Huang, Mario Gauthier, Guang Yang & Qun Wang. (2016) Recent advances in liposome surface modification for oral drug delivery. Nanomedicine 11:9, pages 1169-1185.
Crossref
Crossref
Miri Assayag, Sara Goldstein, Amram Samuni & Neville Berkman. (2015) Cyclic nitroxide radicals attenuate inflammation and Hyper-responsiveness in a mouse model of allergic asthma. Free Radical Biology and Medicine 87, pages 148-156.
Crossref
Crossref
Sufeng ZhangJoerg ErmannMarc D. SucciAllen ZhouMatthew J. HamiltonBonnie CaoJoshua R. KorzenikJonathan N. GlickmanPraveen K. VemulaLaurie H. GlimcherGiovanni TraversoRobert LangerJeffrey M. Karp. (2015) An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Science Translational Medicine 7:300.
Crossref
Crossref
Alf Lamprecht. (2015) Nanomedicines in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 12:4, pages 195-204.
Crossref
Crossref
Dorit Moradov, Helena Shifrin, Efrat Harel, Mirela Nadler-Milbauer, Marta Weinstock, Morris Srebnik & Abraham Rubinstein. (2015) The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis. Gastroenterology Research and Practice 2015, pages 1-10.
Crossref
Crossref
Nawal Al-Henhena, Rozaida Poh Yuen Ying, Salmah Ismail, Wala Najm, Shaden A. M. Khalifa, Hesham El-Seedi & Mahmood Ameen Abdulla. (2014) Chemopreventive Efficacy of Andrographis paniculata on Azoxymethane-Induced Aberrant Colon Crypt Foci In Vivo. PLoS ONE 9:11, pages e111118.
Crossref
Crossref
Christian Lautenschläger, Carsten Schmidt, Dagmar Fischer & Andreas Stallmach. (2014) Drug delivery strategies in the therapy of inflammatory bowel disease. Advanced Drug Delivery Reviews 71, pages 58-76.
Crossref
Crossref
Hongbo Zhang, Mohammed-Ali Shahbazi, Patrick V. Almeida & Hélder A. Santos. 2014. Mucosal Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals
59
97
.
JOHN N. BARRY & ALEXEY A. VERTEGEL. (2014) NANOMATERIALS FOR PROTEIN-MEDIATED THERAPY AND DELIVERY. Nano LIFE 03:04, pages 1343001.
Crossref
Crossref
Julie Carillon, Jean-Max Rouanet, Jean-Paul Cristol & Richard Brion. (2013) Superoxide Dismutase Administration, A Potential Therapy Against Oxidative Stress Related Diseases: Several Routes of Supplementation and Proposal of an Original Mechanism of Action. Pharmaceutical Research 30:11, pages 2718-2728.
Crossref
Crossref
Ana Beloqui, Régis Coco, Mireille Alhouayek, María Ángeles Solinís, Alicia Rodríguez-Gascón, Giulio G. Muccioli & Véronique Préat. (2013) Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. International Journal of Pharmaceutics 454:2, pages 775-783.
Crossref
Crossref
Helena Shifrin, Mirela Nadler-Milbauer, Shai Shoham & Marta Weinstock. (2013) Rivastigmine Alleviates Experimentally Induced Colitis in Mice and Rats by Acting at Central and Peripheral Sites to Modulate Immune Responses. PLoS ONE 8:2, pages e57668.
Crossref
Crossref
Hussain Ali, Eva-Maria Collnot, Maike Windbergs & Claus-Michael Lehr. (2013) Nanomedicines for the treatment of inflammatory bowel diseases. European Journal of Nanomedicine 5:1.
Crossref
Crossref
Mona M.A. Abdel-Mottaleb, Brice Moulari, Arnaud Beduneau, Yann Pellequer & Alf Lamprecht. (2012) Surface-Charge-Dependent Nanoparticles Accumulation in Inflamed Skin. Journal of Pharmaceutical Sciences 101:11, pages 4231-4239.
Crossref
Crossref
Eva-Maria Collnot, Hussain Ali & Claus-Michael Lehr. (2012) Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. Journal of Controlled Release 161:2, pages 235-246.
Crossref
Crossref
Wiebke Niebel, Katharina Walkenbach, Arnaud Béduneau, Yann Pellequer & Alf Lamprecht. (2012) Nanoparticle-based clodronate delivery mitigates murine experimental colitis. Journal of Controlled Release 160:3, pages 659-665.
Crossref
Crossref
Fang Yuan, Geoffrey M. Thiele & Dong Wang. (2011) Nanomedicine development for autoimmune diseases. Drug Development Research 72:8, pages 703-716.
Crossref
Crossref
Efrat Harel, Abraham Rubinstein, Aviram Nissan, Elena Khazanov, Mirela Nadler Milbauer, Yechezkel Barenholz & Boaz Tirosh. (2011) Enhanced Transferrin Receptor Expression by Proinflammatory Cytokines in Enterocytes as a Means for Local Delivery of Drugs to Inflamed Gut Mucosa. PLoS ONE 6:9, pages e24202.
Crossref
Crossref
Jean-Paul Lallès, Dominique Lacan & Jean-Claude David. (2011) A melon pulp concentrate rich in superoxide dismutase reduces stress proteins along the gastrointestinal tract of pigs. Nutrition 27:3, pages 358-363.
Crossref
Crossref
D. G. Harrison, T. J. Guzik, H. E. Lob, M. S. Madhur, P. J. Marvar, S. R. Thabet, A. Vinh & C. M. Weyand. (2010) Inflammation, Immunity, and Hypertension. Hypertension 57:2, pages 132-140.
Crossref
Crossref
Wiebke Ulbrich & Alf Lamprecht. (2009) Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. Journal of The Royal Society Interface 7:suppl_1.
Crossref
Crossref
Boaz TiroshNadine KhatibYechezkel BarenholzAviram NissanAbraham Rubinstein. (2009) Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa. Molecular Pharmaceutics 6:4, pages 1083-1091.
Crossref
Crossref
M. Nadler-Milbauer, A.K. Azab, J. Kleinstern, Y. Barenholz & A. Rubinstein. (2009) In vitro and in vivo analysis of pulsatile biodegradation of mucoadhesive hydrogels. Journal of Drug Delivery Science and Technology 19:4, pages 247-255.
Crossref
Crossref
Yvette Meissner & Alf Lamprecht. (2008) Alternative Drug Delivery Approaches for the Therapy of Inflammatory Bowel Disease. Journal of Pharmaceutical Sciences 97:8, pages 2878-2891.
Crossref
Crossref